COO
Anatomic Incorporated
Stem cell biologist and automation engineer who has developed a wide range of novel technologies based on human induced pluripotent stem cells (hiPSCs) for neurological research applications. These technologies include cGMP compliant differentiation protocols towards the neural fate, a preclinical autologous cellular therapeutic candidate for spinal cord injury, 3D neural bioprinting techniques, and an automated system for hiPSC culture and differentiation for phenotypic drug screening.